Skip to main content
Eating Disorder Treatment and Prevalence Statistics (Updated for 2025–2026)
  • Home
  • Eating Disorder
  • Eating Disorder Treatment and Prevalence Statistics (Updated for 2025–2026)
title-details-01 (Demo)
title-details-02 (Demo)
Eating disorders are serious mental health conditions that affect millions of people of all ages and genders. As of 2026, data shows that these conditions, such as Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder, have the second-highest mortality rate among mental health disorders, just after opioid addiction. This report reviews the most recent 2024–2025 data on prevalence and treatment from ANAD, NEDA, and the WHO.

Overview of Prevalence and Mortality

Eating disorders are more common than most people realize. In 2025, diagnostic rates increased among males and non-binary people.
  • Lifetime Prevalence: Approximately 9% of the U.S. population will struggle with an eating disorder at some point in their lives, amounting to nearly 28.8 million people.
  • Global Impact: Worldwide, eating disorder rates have gone up from 3.4% to 7.8% in the past decade. The biggest increases are in high-income Asian and European countries.
  • Mortality Risks: An eating disorder results in one death every 52 minutes in the United States, often due to cardiovascular failure or co-occurring suicidal ideation.
  • Treatment Gap: Only about one in three people with an eating disorder seek professional help. Even fewer can access specialized residential treatment.
  • Early Intervention Value: Early diagnosis and intervention can improve overall treatment success rates by as much as 70%, particularly in adolescent populations.
  • Co-occurring Disorders: Roughly 50-70% of individuals with an eating disorder also meet the criteria for a co-occurring anxiety or mood disorder.

Success Rates: Therapy vs. Medication

Modern eating disorder treatment uses a team approach, but behavioral therapy is still the main method for long-term recovery.
  • CBT Remission Rates: Cognitive Behavioral Therapy (CBT) alone maintains a remission rate of 40–60% for individuals struggling with Bulimia Nervosa.
  • FDA-Approved Medications: Fluoxetine (Prozac) remains the only FDA-approved medication specifically for Bulimia, while Vyvanse is approved for moderate to severe Binge Eating Disorder.
  • Medication Efficacy: Medications can cut bingeing episodes by 20–30%, but they are less effective for Anorexia Nervosa than behavioral therapy.
  • The Power of Combination: Using both CBT and medication can raise long-term remission rates to 50–70%.
  • Family-Based Treatment (FBT): For teenagers with Anorexia, FBT has a 50–60% success rate. It works better than individual therapy for this age group.
  • DBT and Mood Regulation: Dialectical Behavior Therapy (DBT) helps about 60% of people who also have trouble with mood regulation.

Demographics: Adolescents vs. Adults

Age-specific data for 2025 shows that while eating disorders are often linked to young people, more adults, especially middle-aged women, are affected now.
  • Adolescent Prevalence: About 2.7% of U.S. teens aged 13–18 have a diagnosed eating disorder. Anorexia is the most common diagnosis for this group.
  • Gender Disparities: Anorexia affects about 0.9% of females and 0.3% of males. Since 2021, 12% more males are seeking treatment.
  • Adult Presentation: Bulimia and Binge Eating Disorder are more common in adults. Binge Eating Disorder affects 3.5% of women and 2.0% of men during their lives.
  • Treatment Seeking Behaviors: Teenagers are less likely than adults to seek treatment on their own. Most need a parent to help them get care.
  • Male Diagnosis Rates: About 1 in 20 adolescent males are diagnosed with an eating disorder compared to females.
  • LGBTQ+ Risk Factors: LGBTQ+ youth are diagnosed with eating disorders almost twice as often as cisgender, heterosexual youth.

Inpatient vs. Outpatient Treatment Outcomes

The choice between inpatient and outpatient treatment depends on medical stability. In 2025, the difference in long-term results between the two is getting smaller.
  • Inpatient Initial Success: Residential and inpatient programs have about a 70% initial recovery rate for people with severe, unstable cases.
  • Outpatient Accessibility: Outpatient care has about a 50% success rate and is easier to access for people with milder symptoms.
  • Relapse Prevention: People who get inpatient care have a 10% lower relapse rate in the first year than those who only use outpatient care.
  • Long-Term Remission: After the first year, recovery rates for inpatient and outpatient care become similar once people are stable.
  • Hospitalization Reductions: Early outpatient treatment can lower the chance of future emergency hospital visits by about 30%.

2025 Trends & Public Health Insights

A key trend in 2025–2026 is more attention on how social media affects eating habits and the increase in disordered eating among marginalized groups.
  • Social Media Influence: Teens who spend more than three hours a day on image-focused social media have a 20% higher rate of body dissatisfaction and disordered eating.
  • Growth in Telehealth: Telehealth eating disorder programs have grown by 40% in the past two years, making care much more available in rural areas.
  • The Rise of “Orthorexia”: Orthorexia, or an obsession with healthy eating, is not an official DSM-V diagnosis yet. Still, 2025 reports show it is rising in fitness communities.
  • Margalized PopulationsMarginalized Populations: Research shows that Black and Hispanic people are just as likely as white people to have eating disorders, but they are only half as likely to get a diagnosis.National Sources
  • NEDA (2025): “Eating Disorder Statistics and Research Updates.” https://www.nationaleatingdisorders.org/statistics
  • ANAD (2025): “Eating Disorder Prevalence and Mortality Rates.” https://anad.org/eating-disorders-statistics/
  • SAMHSA (2025): “2024 National Survey on Drug Use and Health (NSDUH) – Eating Disorder Supplement.” https://www.samhsa.gov/data/release/2024-national-survey-drug-use-and-health-nsduh-releases

International Sources

Professional & Peer-Reviewed Sources

  • JAMA Psychiatry (2025): “Efficacy of CBT vs. Medication in Eating Disorder Remission.” https://jamanetwork.com/journals/jamapsychiatry
  • American Journal of Psychiatry (2025): “Long-term Outcomes of Family-Based Treatment for Adolescent Anorexia.” https://ajp.psychiatryonline.org/